AnaptysBio, Inc. Common Stock (ANAB) News
Latest headlines that mention ANAB, newest first · each headline opens the original publisher
- Last price
- $48.77
- Day change
- +0.08%
- Next earnings
- 2026-11-03
ANAB headlines
last 30 daysFirst Tracks Biotherapeutics posted "impressive" results for its celiac disease treatment Monday, and the IPO stock surged. The post Why This IPO Stock, An AnaptysBio Spinoff, Just Surged appeared first on Investor's Business Daily .
Also mentioned with ANAB
30d
Headlines that tag both tickers
ANAB news alerts
Get an alert by email or push when a new headline mentions ANAB.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.